{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T12:00:36Z","timestamp":1772366436040,"version":"3.50.1"},"reference-count":75,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiovascular devices are essential for the treatment of cardiovascular diseases including cerebrovascular, coronary, valvular, congenital, peripheral vascular and arrhythmic diseases. The regulation and surveillance of vascular devices in real\u2010world practice, however, presents challenges during each individual product's life cycle. Four examples illustrate recent challenges and questions regarding safety, appropriate use and efficacy arising from FDA approved devices used in real\u2010world practice. We outline potential pathways wherein providers, regulators and payors could potentially provide high\u2010quality cardiovascular care, identify safety signals, ensure equitable device access, and study potential issues with devices in real\u2010world practice.<\/jats:p>","DOI":"10.1002\/ccd.31053","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T09:14:51Z","timestamp":1713518091000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Device regulation and surveillance in vascular care: Challenges and opportunities"],"prefix":"10.1002","volume":"104","author":[{"given":"Alyssa J.","family":"Pyun","sequence":"first","affiliation":[{"name":"Division of Vascular Surgery and Endovascular Therapy Keck Medical Center of University of Southern California Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3973-3506","authenticated-orcid":false,"given":"Philip P.","family":"Goodney","sequence":"additional","affiliation":[{"name":"Heart and Vascular Center, Dartmouth Health Lebanon New Hampshire USA"},{"name":"The Society for Vascular Surgery's Patient Safety Organization (SVS\u2010PSO) and Vascular Quality Initiative (VQI) Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Eldrup\u2010Jorgensen","sequence":"additional","affiliation":[{"name":"The Society for Vascular Surgery's Patient Safety Organization (SVS\u2010PSO) and Vascular Quality Initiative (VQI) Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Wadzinski","sequence":"additional","affiliation":[{"name":"The Society for Vascular Surgery's Patient Safety Organization (SVS\u2010PSO) and Vascular Quality Initiative (VQI) Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Secemsky","sequence":"additional","affiliation":[{"name":"Division of Vascular Interventions Beth Israel Deaconess Medical Center Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1567-6006","authenticated-orcid":false,"given":"Joaquin E.","family":"Cigarroa","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine Oregon Health Sciences University (OHSU) Portland Oregon USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"Focus areas of regulatory science. Food and Drug Association website. Accessed 3.21.24.https:\/\/www.fda.gov\/science-research\/focus-areas-regulatory-science-report\/focus-areas-regulatory-science-approach"},{"key":"e_1_2_9_3_1","unstructured":"Premarket Approval (PMA). US Food and Drug Administration. Accessed 3.21.2.https:\/\/www.fda.gov\/medical-devices\/premarket-submissions-selecting-and-preparing-correct-submission\/premarket-approval-pma"},{"key":"e_1_2_9_4_1","unstructured":"MAUDE \u2010 Manufacturer and User Facility Device Experience.https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/search.cfm"},{"key":"e_1_2_9_5_1","unstructured":"Postmarket surveillance studies program.https:\/\/www.fda.gov\/medical-devices\/postmarket-requirements-devices\/522-postmarket-surveillance-studies-program. Accessed Sept 302023."},{"key":"e_1_2_9_6_1","unstructured":"MAUDE \u2010 Manufacturer and User Facility Device Experience.https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/search.cfm"},{"key":"e_1_2_9_7_1","unstructured":"2023Medical Device Recalls.https:\/\/www.fda.gov\/medical-devices\/medical-device-recalls\/2023-medical-device-recalls"},{"key":"e_1_2_9_8_1","article-title":"Use of linked registry claims data for long term surveillance of devices after endovascular abdominal aortic aneurysm repair: observational surveillance study","volume":"379","author":"Goodney P","year":"2022","journal-title":"BMJ (Clinical research ed.)"},{"key":"e_1_2_9_9_1","unstructured":"ThomasK Silver\u2010GreenbergJ GebeloffR.They lost their legs. Doctors and health care giants profited.The New York Times2023."},{"key":"e_1_2_9_10_1","unstructured":"CMS NCA: Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting."},{"key":"e_1_2_9_11_1","unstructured":"FDA: Total Product Life Cycle for Medical Devices.https:\/\/www.fda.gov\/about-fda\/cdrh-transparency\/total-product-life-cycle-medical-devices"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2014.04.017"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2018.06.019"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2015.04.454"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2022.02.020"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2016.03.416"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2020.06.054"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.06.048"},{"key":"e_1_2_9_19_1","unstructured":"Food and Drug Administration.UPDATE: The FDA Reminds Patients and Health Care Providers of the Importance of At Least Yearly Lifelong Follow\u2010Up with Use of Endologix AFX Endovascular AAA Graft Systems: FDA Safety Communication.2021."},{"key":"e_1_2_9_20_1","unstructured":"Food and Drug Administration.Class 2 Device Recall AFX Endovascular AAA System."},{"key":"e_1_2_9_21_1","unstructured":"Food and Drug Administration.Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System."},{"key":"e_1_2_9_22_1","unstructured":"Endologix AFX Endovascular AAA Graft Systems and Risk of Type III Endoleak: FDA Safety Communication."},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062123"},{"key":"e_1_2_9_24_1","unstructured":"Post Approval Studies Database:VQI and VISION EVAR Registry Analysis."},{"key":"e_1_2_9_25_1","unstructured":"WaldmanAIn the \u201cWild West\u201d of Outpatient Vascular Care Doctors Can Reap Huge Payments as patients Risk Life and Limb."},{"key":"e_1_2_9_26_1","unstructured":"WaldmanA.Steak dinners sales reps and risky procedures: Inside the big business of clogged arteries."},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2022.03.864"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2018.12.059"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.12.048"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2016.08.112"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.10.090"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2022.10.025"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2022.02.034"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012081"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/1538574418772459"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.27635"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.075770"},{"issue":"2","key":"e_1_2_9_38_1","article-title":"Exercise for intermittent claudication","author":"Leng GC","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530120067043"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2014.12.009"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2022.04.012"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2021.01.061"},{"key":"e_1_2_9_43_1","unstructured":"2019Abbott Reimbursement Guide: MS Physician Fee Schedule.https:\/\/www.cardiovascular.abbott\/content\/dam\/bss\/divisionalsites\/cv\/pdf\/guides\/2019_Physician_Fee_Schedule_Guide_peripheral_and_coronary_updated_on_12_11_2018_Revised_MZ_v2.pdf. Accessed Sept 302023."},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.122.009199"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011245"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016900"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.10.002"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.27141"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044697"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.12.012"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.04.041"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.08.025"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.040518"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-019-0069-x"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.0325"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.020"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008528"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.01.197"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2018.10.021"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz698"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018149"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005206"},{"key":"e_1_2_9_65_1","unstructured":"Paclitaxel\u2010Coated Balloons and Stents for Peripheral Arterial Disease."},{"key":"e_1_2_9_66_1","unstructured":"UPDATE: Paclitaxel\u2010Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality \u2010 Letter to Health Care Providers.2023."},{"key":"e_1_2_9_67_1","unstructured":"Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting."},{"key":"e_1_2_9_68_1","unstructured":"Percutaneous Transluminal Angioplasty (PTA)."},{"key":"e_1_2_9_69_1","unstructured":"Centers for Medicare and Medicaid Services. National Coverage Analysis. Proposed Decision Memo: Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting."},{"key":"e_1_2_9_70_1","unstructured":"MSCA Formal Request for Reconsideration of NCD 20.7."},{"key":"e_1_2_9_71_1","unstructured":"SVS VQI2022Annual Report."},{"key":"e_1_2_9_72_1","unstructured":"Post\u2010Approval Studies (PAS) Database: SAPIEN 3 Aortic Valve\u2010in\u2010Valve Comp Surv."},{"key":"e_1_2_9_73_1","unstructured":"Post\u2010Approval Studies (PAS) Database: TAVR."},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2023.03.014"},{"key":"e_1_2_9_75_1","first-page":"131","volume-title":"Eur J Vasc Endovasc Surg","author":"Mao J","year":"2023"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.2738"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.31053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:23:06Z","timestamp":1720797786000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.31053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1002\/ccd.31053"],"URL":"https:\/\/doi.org\/10.1002\/ccd.31053","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]},"assertion":[{"value":"2024-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}